Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.56 | N/A |
| PEG Ratio (TTM) | -0.35 | N/A |
| P/S Ratio (TTM) | 0.29 | N/A |
| P/B Ratio (TTM) | 0.94 | N/A |
| P/FCF Ratio (TTM) | 5.75 | N/A |
| Price to 5YR AVG Earnings Ratio | 1.73 | N/A |
| Price to 5YR AVG FCF Ratio | 1.64 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.52% | N/A |
| ROE (TTM) | 3.55% | N/A |
| Net Profit Margin (TTM) | 1.09% | N/A |
| ROIC 5YR AVG | 188.43% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -30.31% | 44.69% | 19.36% |
| Revenue | -11.98% | 45.56% | 21.70% |
| Net Income | -30.08% | 43.72% | 17.58% |
| Cash Flow | -11.69% | 25.33% | 31.53% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.11 | N/A |
| Quick Ratio (TTM) | 2.55 | N/A |
| D/E Ratio (TTM) | 0.03 | N/A |
| Interest Coverage (TTM) | 8.87 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 5.34 | N/A |
| LTL to 5YR AVG FCF | 0.14 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.83% | N/A |